Sign Up to like & get
recommendations!
0
Published in 2025 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.sabcs24-p3-03-26
Abstract: Neoepitopes, which are unique HLA-binding peptides produced by cancer cells, are potential cancer-specific targets for T cell-based immunotherapies. However, there are ongoing challenges for the selection and prioritization of neoepitopes for therapeutics. First, next generation…
read more here.
Keywords:
cancer;
breast cancer;
long read;
fusion derived ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2017.01113
Abstract: Somatic non-synonymous mutations in the DNA of tumor cells may result in the presentation of tumor-specific peptides to T cells. The recognition of these so-called neoepitopes now has been firmly linked to the clinical success…
read more here.
Keywords:
vast dynamic;
exploiting vast;
neoepitope;
challenges exploiting ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1119498
Abstract: Recurrent neoepitopes are cancer-specific antigens common among groups of patients and therefore ideal targets for adoptive T cell therapy. The neoepitope FSGEYIPTV carries the Rac1P29S amino acid change caused by a c.85C>T missense mutation, which…
read more here.
Keywords:
cell;
neoepitope;
high affinity;
rac1p29s ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Biomedicines"
DOI: 10.3390/biomedicines13112715
Abstract: Background/Objectives: Glioblastoma multiforme (GBM) is an aggressive primary brain tumor with limited therapeutic options. Neoantigen-based immunotherapy offers a promising avenue, but its efficacy primarily depends on the ability of somatic mutations to generate immunogenic peptides…
read more here.
Keywords:
hla class;
hla;
alphafold2 multimer;
neoepitope ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14071842
Abstract: Simple Summary T cell-based immunotherapy has achieved remarkable clinical responses in patients with cancer. Neoepitope-specific T cells can specifically recognize mutated tumor cells and have led to tumor regression in mouse models and clinical studies.…
read more here.
Keywords:
cell;
tcr;
neoepitope;
specific tcrs ... See more keywords